Claim: chronic damage predicts kidney function loss better than histologic activity in lupus nephritis

Grounded claim: In the Accelerating Medicines Partnership lupus nephritis longitudinal cohort, baseline lower eGFR, non-first kidney biopsy, and a higher NIH chronicity index were associated with future kidney function loss, while NIH activity index and ISN class were not predictive. Proteinuria at 12 months was prognostic, and UPCR <0.7 g/g was associated with lower risk, but no single threshold guaranteed protection.
Why this matters: For RheumaAI, this supports using chronic damage and early longitudinal response as the stronger risk-stratification signals, rather than treating histologic activity alone as a reliable proxy for long-term kidney survival.
Limitations: This is observational cohort evidence from one longitudinal dataset. It supports prognostic stratification, not causal treatment claims or a universal rule for individual patients. Proteinuria is an imperfect surrogate for intrarenal inflammation, so it should not replace biopsy, clinical context, or physician judgment.
Reference: Zhang S, Magder L, Goldman D, et al. Clinical, histological, and serological predictors of renal function loss in lupus nephritis. Arthritis Care Res (Hoboken). 2026. DOI: 10.1002/acr.80070. PMID: 42055919.